About the Company

[Summary] 专注医药研发与生产服务外包及微生态医疗领域

睿智医药科技股份有限公司系一家领先的医药研发外包服务机构CROCDMO业务,秉持科技为本,技术为先、全球运营、卓越品质的发展理念,致力于持续为全球医药健康产业创新赋能。为全球制药企业、生物技术研发公司及科研院校提供涵盖生物药及化学药的临床前研发CRO业务与临床药物开发生产CDMO的新药研发生产一体化服务。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

睿智医药 Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market: 创业板
  • Deal: 深交所

睿智医药 Recruitment Overview / Current Status (134 open positions)

Manage

睿智医药 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

睿智医药 Related Industry Tags

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 49,796.3992万(元)
Legal Representative: WOO SWEE LIAN
Date Established:
Credit Code: 9144070072115339X0
Registered Address: 江门市江海区胜利南路164号

Partners & Suppliers

2022年与苑东生物签署战略合作协议,针对高端化学药研发外包 Source
合作客户 化学药工艺开发与生产
睿智医药为信达生物提供大分子药物早期研发服务 Source
合作客户 药物发现及临床前研究
成都先导与睿智医药达成战略合作协议,利用DNA编码化合物库技术加速新药发现 Source
供应商 DEL药物筛选平台
赛默飞与睿智医药战略合作,提供一次性生物反应器等生物工艺解决方案 Source
供应商 生物工艺设备与耗材
皓元医药向睿智医药提供小分子砌块和工具化合物 Source
供应商 化学试剂与分子砌块

People who follow 睿智医药 also follow

睿智医药 Competitors (Similar Companies)

“To develop high-quality biologics that are accessible and affordable f”
“Research, development, and production of anti-tumor and surgical medic”
“Promoting human health”
“Gene technology benefits humanity”
“Technological innovation and commercial application of pharmaceutical ”
“One of the leading enterprises in the pharmaceutical industry”
“Products for the diagnosis and treatment of allergic diseases”
“A renowned enterprise in China's liver disease and anti-tumor fields”
制药/药业 药物研发 生物制药 医药
“Continuously innovating to bring patients medicines that significantly”
“Helping partners successfully develop new drugs, reducing R&D costs an”
医药 新药研发 CRO 医药CRO
“Bring the digital world to every person, home, and organization, to bu”
“Making drugs and cures accessible to all”
医药 抗体 药物研发 生物医药

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates